<DOC>
	<DOC>NCT02088008</DOC>
	<brief_summary>A randomized, open-label, single dosing, two-way crossover clinical trial to compare the safety/tolerability and pharmacokinetics of the combination of Cilnidipine 10mg and Valsartan 160mg in comparison to each component coadministered in healthy male volunteers.</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan</brief_title>
	<detailed_description />
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Cilnidipine</mesh_term>
	<criteria>Age between 20 and 40 Signed informed consent Has a history of hypersensitivity to IP ingredients Hypertension or hyportension</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>